In an interview with The Wall Street Journal, BioNTech CEO Ugur Sahin said that although Omicron may infect more vaccinated people, they may still be protected from serious diseases.
The CEO of COVID-19 vaccine manufacturer BioNTech has a message to those concerned about the Omicron variant of the coronavirus: stay calm.
In an interview with The Wall Street Journal (Pay zone) On Tuesday, Ugur Sahin, the co-founder of BioNTech and invented one of the first COVID-19 vaccines, said that although Omicron variants may cause more vaccinated people to be infected, they may still be predicted to not get it. Serious illness.
“Our message is: don’t panic, the plan remains the same: speed up the third strengthening of the injection management,” he told the Wall Street Journal.
Sahin said that the BioNTech mRNA jab, which he and his research team invented in January 2020 and then co-developed with the US pharmaceutical giant Pfizer, has proven that it can prevent serious diseases caused by other vaccinated virus variants and has been contracted.
He pointed out that although Omicron may be better at avoiding vaccine-generated antibodies than Delta, due to the large number of mutations in the new variant, Omicron is unlikely to bypass the body’s immune response to infected T cells.
“Our belief [that the vaccines work against Omicron] Rooted in science: if the virus achieves immune escape, it will achieve it against antibodies, but there is a second immune response that can prevent serious diseases-T cells,” he told the Wall Street Journal.
An interview with the head of BioNTech followed closely Comment from the CEO of Moderna Stephane Bancel (Stephane Bancel) Tuesday. In an interview with the Financial Times (Pay zone), Bancel warned that the current COVID-19 jab is much less effective on Omicron.
“There is no world, I think, where [the effectiveness] It’s the same level… We have the same experience as Delta Air Lines,” he said.
“I think this will be a substantial drop. I just don’t know how much, because we need to wait for the data. But all the scientists I talked to… are saying,’This is not going to be a good thing.'”
Bancel’s remarks shook European and Asian markets, causing stocks and oil prices to fall.
In an interview with The Wall Street Journal, Shaheen said that it will take about 100 days to bring the adjusted jab against Omicron to the market, but this may not be necessary.
He told the Wall Street Journal: “We have a plan to give people a third injection. We have to stick to this plan and speed up.” “Whether we need to adapt to the additional protection of the vaccine remains to be seen. We will talk about it later.”